Abingworth
0 followers
About Abingworth
Abingworth is a trans-atlantic bio-science investment firm that works with entrepreneurs to turn breakthrough science into breakthrough medicine. With over thirty years of experience, they have invested in over a hundred young companies and helped them navigate through various scenarios to build successful companies.
Recent News
Recent Deals
Solve Therapeutics Raises $120M in Oversubscribed Funding Round
November 17, 2025
Addition Therapeutics Secures $100M Funding to Advance Genomic Medicine
December 17, 2025
R1 Therapeutics Raises $77.5M Series A to Advance Kidney Disease Drug
March 18, 2026
Cytospire Raises $83M Series A to Develop Pan‑gamma Delta T‑cell Engagers
May 5, 2026